It is a genetic defect which leads to reduced secretions in various organs. Dornase alpha hydrolyses extra-cellular DNA from the neutrophils in bronchial mucus and increases its liquidity drastically.
Briefly explain what neonatal respiratory distress syndrome is, what the general treatment strategies involve and how cortisone and exogenous surfactants solve the problem.
Neonatal Respiratory distress syndrome is also known as hyaline membrane disease and occurs in premature babies. It is basically when the surface-active material that covers the respiratory unit of the airways is not form, when babies are born prematurely.
Intensive monitoring of respiratory and circulatory status is essential . Exogenous surfactants are administered exogenously at room temperature( by means of a catheter into the lungs
A short course of corticosteroids is effective to boost endogenous surfactant production and is a cheaper alternative.
Oxygen therapy is administered with air at room temperature to ensure oxygenation. a continuous positive pressure improves ventilation and keeps the alveoli open in order to prevent collapse. It is administered in order to prevent collapse.
Dangers. oxygen toxicity causes reduced drug exchange, hypoxia and death in extreme cases. It can also cause retinal damage and blindness.
Neonatal apnoea occurs when the respiratory centre in the medulla has not yet fully developed in premature babies to stimulate continuous breathing.
Methylxanthines, caffeine and theophylline stimulate the CNS and IV administration of these drugs help solve the problem.
Rhinitis and rhinorrhoea are caused by cold and flu, sinitus, allergen exposure (IgE mediated inflammation and physiological response due to stimuli (heat, smoke and cold weather).
Antihistamine e.g. diphenhydramine
corticosteroids e.g. mometasone
mucolytics e.g. mesna
alpha-1 agonists e.g. phenylephrine
Anti-allergy drugs (sodium cromoglycate)
Decongestants MOA ( causes vasoconstriction of the mucosal blood vessels and decreases oedema of nasal mucosa)
short-acting drugs (4-6 hours) ephedrine, phenylephrine
intermediate acting drugs (8-10 hours), xylometazoline
long acting drugs (12 hours) oxymetazoline
They are administered in the topical dosage form (nasal spray, drops and jellies) and inhalation of volatile compounds.
Also known as rebound congestion or Privinism results from an overdose of local preparations. basically presents after chronic treatment with decongestants, where the permanent vasoconstriction with poor local blood supply leads to damage of the mucous membranes of the nose with inflammation and swelling.
Treatments: stop using the decongestants. gradually decrease your use of the medicine and for mild congestion use a saline nasal spray.
1st generation antihistamines are multipotent competing antagonist and blocks muscarinic receptors. Antimuscarinic drugs will reduce the secretions of both the upper and lower airways and are included in preparations for colds and clear up rhinnorhoea. 1st generation anti-histamines can cause sedation.
2nd generation anti-histamine do not block muscarinic receptors and are used in the long term or short term treatment of allergic rhinitis. these drugs do not help with the clear up of cold rhinitis, because histamine plays no part in cold rhinitis ( only bradykinin)
corticosterioids- administered for allergic rhinitis, nasal sprays administered through nasal cavity.
anti-allergy drugs- allergic rhinitis and administered as a nasal spray
mesna- when nasal spray secretions is sticky and administered as a nasal spray.
normal salt solution- allergic rhinitis, mild congestion (nose drops)
Chronic obstructive pulmonary disease is basically a group of diseases (emphysema, Bronchial asthma, and chronic bronchitis) which causes blockage of airflow and breathing problems.
Chronic bronchitis- aetiology- long term exposure to irritants, smoking.
-pathophysiology- obstructive airway disease due to an increase secretion of mucus, decrease in mucus clearance and frequent bacterial respiratory infections.
Emphysema- aetiology- smoking and irritant
-pathophysiology- air sacks (alveoli) is damaged and the inner walls of the alveoli weakens and rupture creating larger than normal air spaces and this reduces the surface area of the lungs and amount of oxygen reaching the lungs.
Treatment includes anticholinergics, B2-agonists and slow-release theophylline, corticosteroids and oxygen therapy.
It is first line bronchodilator in the treatment of chronic bronchitis and it is used in treating the symptoms of chronic bronchitis and not in the treatment of bronchial asthma
It improves the contraction function of the diaphragm and thus increases ventilatory capacity.
If a patient presents with low oxygen levels in their blood oxygen therapy can be used to restore the oxygen levels in the blood and prevention of hypoxia.
According to Hashimoto (2021) Sars Cov-2 binds itself to the ACE2 receptor on the cells and this ultimately results in the activation of the acid sphingomyelinase which is responsible for the conversion of sphingomyelin to ceramide. ASM/Ceramide system can facilitate viral entry. Fluvoxamine, which is an antidepressant inhibits ASM and formation of ceramide-enriched membrane domains and this results in decreased viral entry. The sigma-1-receptor agonist fluvoxamine may alternate ER stress due to SARS-COV-2 replication in cells, thus resulting in blockade against inflammatory events. thus early administration of fluvoxamine may block/delay clinical deterioration in individuals with SARS-COV-2 infections.
Resource
Hashimoto, Y., Suzuki, T., Hashimoto, K. 2021. Old drug Fluvoxamine, new hope for covid-19. Eur Arch Psychiatry an Neurosci (2021). https://doi.org/10.1007/500406-021-01326-z
An increase in blood flow stimulates endothelium-dependent vasodilation by increasing shear stress on the endothelium, both in conduit and resistance vessels.
Constitutive enzymes: they are always produced whether or not a suitable substrate is present and this affects the process by which the synthesis occur and it is always present in the organism in constant amounts .
inducible enzymes: only expressed under conditions in which it is clearly of adaptive value ( used for breaking down of things in the cell).
The physiological production of NO is important for blood pressure regulation and blood flow distribution. A hyperproduction of NO by the inducible form of NO synthase (iNOS) may contribute to the hypotension, cardio depression and vascular hyporeactivity in septic shock.
Nitric oxide.
Nitric oxide is a potent and rapid inducer of methemoglobinemia. Exposure to Nitric Oxide may result in changes of the pulmonary system.
NO is considered as a pro-inflammatory mediator. It induces inflammation due to over production in abnormal circumstances. Advantages: NO inhibitors represents an important therapeutic advance in the management of inflammatory diseases. They are proved to be used for the treatment of of NO-induced inflammation. Disadvantages: due to impaired production of vasoconstriction, inflammation and tissue damage.
Autism spectrum disorder, schizoprenia, (may play a role in the development of it). Bipolar disease, migraine, epilepsy, addiction.
Decrease in blood pressure (hypotension). It increases blood pressure by constricting the blood vessels, it triggers thirst and the desire for salt. Increased levels of angiotensin can result in excess fluid being retained by the body.
The ACE inhibitors lowers blood pressure by preventing the production of Angiotensin II, while Angiotensin receptor blockers reduce the action of angiotensin II to prevent blood vessel constriction.
It helps to relax the veins and arteries to lower blood pressure and it prevents an enzyme in the body from producing angiotensin II which is a substance that narrows blood vessels.
They bind the AT1 receptor found in vascular smooth muscle and adrenal gland.
Kinins induce vasodilation, Increasing blood flow throughout the body and a brief fall in blood pressure.
Bradykinin displays the highest affinity for B2 ( bradykinin 2 Receptors)
Natriuretic Peptides may be administered as recombinant ANP, recombinant BNP or ularitide. They produce vasodilation and natriuresis and have been investigated for the treatment of congestive heart failure. Natriuretic Peptides causes vasodilation and this helps to dilate the arteries (increase in blood flow) and this leads to a fall in blood pressure and this is effective in the treatment of hypertension.
Neprilysin is a zinc-dependent metalloprotease and it blocks Ang II receptors. It is used to treat high blood pressure and heart failure. By blocking its action it prevents the breakdown of natriuretic peptides. Drugs are omapatrilat, sampatrilat and fasidotrilat.
endothelium-derived vasodilator/ endothelium-derived relaxing factor- Nitric oxide: plays a role in endothelial functions.
endothelium-derived vasoconstrictors/ endothelium-derived contracting factors- Endothelin-1 and Cox-derived thromboxane.